Method for treating inflammatory bowel disease
    5.
    发明申请
    Method for treating inflammatory bowel disease 审中-公开
    炎症性肠病的治疗方法

    公开(公告)号:US20070122384A1

    公开(公告)日:2007-05-31

    申请号:US11641163

    申请日:2006-12-19

    申请人: Jan Ohrstrom

    发明人: Jan Ohrstrom

    IPC分类号: A61K38/36 A61K38/21

    摘要: A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombinant. The interferon beta used can be naturally occurring interferon beta, interferon beta-1a or interferon beta-1b.

    摘要翻译: 一种治疗炎性肠病的方法,其通过将I型干扰素与因子XIII结合给患有该疾病的哺乳动物。 IBD可能是溃疡性结肠炎或克罗恩氏病。 所用的因子XIII可以是重组体或非重组体。 所用的干扰素β可以是天然存在的干扰素β,干扰素β-1a或干扰素β-1b。

    Method for treating inflammatory bowel disease
    7.
    发明申请
    Method for treating inflammatory bowel disease 审中-公开
    炎症性肠病的治疗方法

    公开(公告)号:US20060104946A1

    公开(公告)日:2006-05-18

    申请号:US10525271

    申请日:2003-08-25

    申请人: Jan Ohrstrom

    发明人: Jan Ohrstrom

    摘要: A method for treating inflammatory bowel disease by administering interferon beta in conjunction with factor XIII to a mammal afflicted with the disease. The IBD may either be ulcerative colitis or Crohn's disease. The factor XIII used may be recombinant or nonrecombinant. The interferon beta used can be naturally occurring interferon beta, interferon beta-1a or interferon beta-1b.

    摘要翻译: 一种治疗炎性肠病的方法,其通过将I型干扰素与因子XIII结合给患有该疾病的哺乳动物。 IBD可能是溃疡性结肠炎或克罗恩氏病。 所用的因子XIII可以是重组体或非重组体。 所用的干扰素β可以是天然存在的干扰素β,干扰素β-1a或干扰素β-1b。